Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-06-13
1992-02-18
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, 514878, 514879, A61K 3702, A61K 3724
Patent
active
050894722
ABSTRACT:
Administration of a Growth Hormone Releasing factor (GRF) at effective dosage levels improves the mental function of attention or short term memory in a subject in need of the treatment. The method of treating comprises the administration to the subject of an effective mental function improving amount of a Growth Hormone Releasing Factor.
REFERENCES:
patent: 4747825 (1988-05-01), Linkie
patent: 4939124 (1990-07-01), Cacabelos
International Symposium on Somatostatin, Madrid, Spain, Oct. 7-8, 1986.
Cacabelos et al., Hormone Research, 29, 129-132 (1988).
Webster's Seventh New Collegiate Dictionary, G. C. Merriam Company, Springfield, Mass., 1967, p. 529.
Baudry in Neutral Plasticity: A Lifespan Approach, edited by Petit, Alan R. Liss, Inc., New York, 1988, pp. 125-141.
International Symposium on Somatostatin: Recent Advances in Basic Research and Clinical Applications held by The European Neuroendocrine Assocation, Madrid, Spain, oct. 7-8, 1986, Cacabelos et al.
Alonso Thomas O.
Cacabelos Ramon
Vila Francisco R.
Laboratorios Serono S.A.
Moezie F. T.
LandOfFree
Use of growth hormone releasing factor for improving mental func does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of growth hormone releasing factor for improving mental func, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of growth hormone releasing factor for improving mental func will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1823594